Mill Creek Capital Advisors, LLC Adagene Inc. Transaction History

Mill Creek Capital Advisors, LLC

  • $4.08 Billion
  • Q1 2025

A detailed history of Mill Creek Capital Advisors, LLC transactions in Adagene Inc. stock. As of the latest transaction made, Mill Creek Capital Advisors, LLC holds 199,610 shares of ADAG stock, worth $351,313. This represents 0.01% of its overall portfolio holdings.

Number of Shares
199,610
Previous 199,610 -0.0%
Holding current value
$351,313
Previous $397,000 23.68%
% of portfolio
0.01%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 29, 2025
BUY
$1.88 - $3.15 $204,359 - $342,411
108,702 Added 119.57%
199,610 $397,000
Q3 2024

Nov 06, 2024
BUY
$2.12 - $3.49 $192,724 - $317,268
90,908 New
90,908 $201,000

Others Institutions Holding ADAG

# of Institutions
13
Shares Held
10.4M
Call Options Held
0
Put Options Held
0
View Full List

About Adagene Inc.

ADAG Quotes by TradingView
  • Ticker ADAG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,423,200
  • Market Cap $76.4M
  • Description
  • Adagene Inc., a clinical stage biopharmaceutical company, engages in the research, development, and production of monoclonal antibody drugs for cancers. The company's product candidates include ADG106, a human ligand-blocking agonistic anti-CD137 monoclonal antibodies (mAbs) that is in Phase 1b/2 clinical trials for the treatment advanced solid ...
More about ADAG
Track This Portfolio

Track Mill Creek Capital Advisors, LLC Portfolio

Follow Mill Creek Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mill Creek Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mill Creek Capital Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email